Screening for endometrial carcinoma in asymptomatic women, including those receiving tamoxifen;Screening asymptomatischer frauen auf endometriumkarzinom mit besonderer berucksichtigung des screenings unter tamoxifen-behandlung

Geburtshilfe und Frauenheilkunde

Volumn 60, Issue 6, 2000, Pages 297-301

  Petru, E ^a   Kurschel, S ^b   Walsberger, K ^a  

^a Geburtshilflich Gynakologische Universitats Klinik   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

CANCER SCREENING; CANCER STAGING; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; POSTMENOPAUSE; REVIEW; SURVIVAL RATE; VAGINA BLEEDING; VAGINA DISCHARGE;

EID: 0034039419     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9535     Document Type: Review

References (35)

1. Archer D, McIntre-Seltman K, Wilborn W, Dowling E, Cone F, Creasy G, Kafrissen M. Endometrial morphology in asymptomatic postmenopausal women. Amer J Obstet Gynecol 1991; 165: 317-322
2. Barakat R. Screening for endometrial cancer in a patient receiving tamoxifen for breast cancer. J Clin Oncol 1999; 17: 1967-1968
3. Barakat R, Gilewski T, Almadrones L, Saigo P, Venkatraman E, Hoskins W. The effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study. Proc ASCO 1999; 18: 358a
4. Berliere M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: A need for systematic pretreatment screening. Obstet Gynecol 1998; 91: 40-44
5. Bertelli G, Venturini M, Del Mastro L, Garrone O, Cosso M, Gustavino C, Cusimano E, Guido T, Nicolo G, Rosso R. Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients. Breast Cancer Res Treat 1998; 47: 41-46
6. Brooks S, Yeatts-Peterson M, Baker S, Reuter K. Thickened endometrial stripe and/or endometrial fluid as a marker of pathology: Fact or fancy? Gynecol Oncol 1996; 63: 19-24
7. Burk J, Lehman H, Wolf F. Inadequacy of Papanicolao smears in the detection of endometrial cancer. New Engl J Med 1974; 270: 191-192
8. Cecchini S, Ciatto S, Bonardi R, Mazzotta A, Grazzini G, Pacini P, Muraca M. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen. Gynecol Oncol 1996; 60: 409-411
9. Cohen I, Rosen D, Shapira J, Cordoba M, Gilboa S, Altaras M, Yigael D, Beyth Y. Endometrial changes with tamoxifen: Comparison between tamoxifen-treated and nontreated asymptomatic postmenopausal breast cancer patients. Gynecol Oncol 1994; 52: 185-190
10. Cohen I, Tepper R, Rosen D, Shapira J, Cordoba M, Dror Y, Altaras M, Beyth Y. Continous tamoxifen treatment in asymptomatic postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 1994; 55: 138-143
11. Early Breast Cancer Trialist's Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351: 1451-1467
12. Eddy G, Wojtowycz M, Piraino P, Mazur M. Papanicolao smears by the Bethesda system in endometrial malignancy: Utility and prognostic importance. Obstet Gynecol 1997; 90: 999-1003
13. Franchi M, Ghezzi F, Donadello N, Zanaboni F, Beretta P, Bolis P. Endometrial thickness in tamoxifen-treated patients: An independent predictor of endometrial disease. Obstet Gynecol 1999; 93: 1004-1008
14. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H, Yamasaki F. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance. Gynecol Oncol 1999; 72: 273-277
15. Grönross M, Salmi T, Vuento M, Jalava A, Tyrkkö J, Maatela J, Aromaa A, Siegberg R, Savolainen E. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer 1993; 71: 1279-1282
16. Gull B, Karlsson B, Milsom I, Wikland M, Granberg S. Transvaginal sonography of the endometrium in a representative sample of postmenopausal women. Ultras Obstet Gynecol 1996; 7: 322-327
17. Kedar R, Bourne T, Collins W, Ashley S, Cosgrove D, Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994; 343: 1318-1321
18. Koss L, Schreiber K, Oberlander S, Moukhtar M, Leveine H, Moussouris H. Screening of asymptomatic women for endometrial cancer. Obstet Gynecol 1981; 57: 681-691
19. Langer R, Pierce J, O'Hanlan K, Johnson S, Espeland M, Trabal J, Barnabei V, Merino M, Scully R. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. New Engl J Med 1997; 337: 1792-1798
20. Lindgren R, Mattson L, Andersson K, Lagrelius A, Sandin K, Karlsson K, Risberg B. Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy. Brit J Obstet Gynaecol 1999; 106: 421-426
21. Love C, Muir B, Scrimgeour J, Leonard R, Dillon P, Dixon J. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999; 17: 2050-2054
22. McGonigle K, Marx H, Morgan R, Maryon T, Chen E, Roy S, Vasilev S, Wong P, Roach L, Wilczynski P, Simpson J. Uterine effects of tamoxifen: A prospective study. Gynecol Oncol 1994; 74: 324-325
23. Mourits M, Van der Zee A, Willemse H, Hoor T, Hollema H, De Vries E. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Gynecol Oncol 1999; 73: 21-26
24. Obwegeser R, Chalubinsky K, Turnheim K, Auerbach L. Klinische Relevanz sonomorphologischer Veränderungen des Endometriums unter Tamoxifentherapie. Geburtsh Frauenheilk 1997; 57: 371-375
25. Osmers R, Völksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma? Lancet 1990; 335: 1569-1571
26. Runowicz C, Costantino J, Kavanagh M, Geyer C, Daly M, Lewis G, Levy L, Wickerham D, Wieand H. National surgical adjuvant breast and bowel project (NSABP) breast cancer prevention trial summary analysis of transvaginal sonography and endometrial biopsy in detecting endometrial pathology. Proc ASCO 1999; 18: 358a
27. Schmidt T, Rein D, Römer T, Straube W, Mallmann P. Hysteroskopische Befunde bei asymptomatischen postmenopausalen Patientinnen mit sonographisch suspektem Endometrium - Ein Vergleich mit sonographischen und histologischen Befunden. Geburtsh Frauenheilk 1999; 59: 163-166
28. Seoud M, Shamseddine A, Khalil A, Salem Z, Saghir N, Bikhazi K, Bitar N, Azar G, Kaspar H. Tamoxifen and endometrial pathologies: A prospective study. Gynecol Oncol 1999; 75: 15-19
29. Tepper R, Beyth Y, Altaras M, Zalel Y, Shapira J, Cordoba M, Cohen I. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 1997; 64: 386-391
30. Timmermann D, Deprest J, Bourne T, Van der Berghe I, Collins W, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Amer J Obstet Gynecol 1998; 179: 62-70
31. Tsuda H, Kawabata M, Yamamoto K, Inoue T, Umesaki N. Prospective study to cmpare endometrial cytology and transvaginal ultrasonography for identification of endometrial malignancies. Gynecol Oncol 1997; 65: 383-386
32. Turaine P, Driguez P, Cartier I, Yaneva H, Kuttenn F, Mauvais-Jarvis P. Lack of induction of endometrial hyperplasia with tamoxifen. Lancet 1995; 345: 254-255
33. Vuento M, Maatela J, Tyrkkö J, Laippala P, Grönroos M, Salmi T. A longitudinal study of screening for endometrial cancer by endometrial biopsy in diabetic females. Int J Gynecol Cancer 1995; 5: 390-395
34. Vuento M, Stenman U, Pirhonen J, Mäkinen J, Laippala P, Salmi T. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer. Gynecol Oncol 1997; 64: 141-146
35. Vuento M, Pirhonen J, Mäkinen J, Tyrkkö J, Laippala P, Grönroos M, Salmi T. Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and colour Doppler sonography. Brit J Obstet Gynaecol 1999; 106: 14-20